Recombinant prothrombin kringle domains with antitumor properties, were studied using LLC tumor cells and reported that treatment with E. Coli expressed recombinant prothrombin kringle domain-2 not only inhibited tumor growth significantly but also prevented tumor metastasis [62]. Here, F2 is linked to neoplasm.